Legal Opinion
LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION
District Court, D. New Jersey
Decided January 21, 2022No. 2:12-cv-00995Unknown
1Opinion
Not for Publication UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY In re: Lamictal Direct Purchaser Antitrust Litigation Civil Action No. 12-995 OPINION & ORDER John Michael Vazquez, U.S.D.J. This antitrust class action involves the allegedly artificially inflated pricing of the brand drug Lamictal, manufactured by Defendant SmithKline Beecham Corporation d/b/a GlaxoSmithKline (“GSK”), and its generic competitor lamotrigine, manufactured by Defendants Teva Pharmaceutical Industries LTD and its subsidiary Teva Pharmaceuticals USA, Inc. (collectively “Teva”). Presently before the Court is…
2Cases cited3 opinions
- United States v. GibbsCourt of Appeals for the Third Circuit · 1999
- American Civil Liberties Union v. MukaseyCourt of Appeals for the Third Circuit · 2008
- Scopia Mortgage Corp. v. Greentree Mortgage Co.District Court, D. New Jersey · 1998